Skip to main content

Table 1 Characteristics of 117 patients with hepatic veno-occlusive disease at the time of diagnosis

From: Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study

Characteristic Obtained data
Age (years) 63.0 (52.5–69.0)
Male/female (%) 67/33
Clinical manifestations, n (%)
 Ascites 116 (99.1)
 Abdominal distention 115 (98.3)
 Poor appetite 48 (41.0)
 Nausea, vomiting 19 (16.2)
 Malaise 39 (33.3)
 Lower limb oedema 46 (39.3)
 Hepatomegaly 82 (70.0)
 Splenomegaly 40 (34.2)
 Right upper quadrant pain 23 (19.7)
 Weight gain 21 (18.0)
 Encephalopathy 19 (16.2)
 Variceal bleeding 3 (2.6)
Laboratory tests
 WBC (109/L) 6.1 (5.0–8.7)
 RBC (1012/L) 4.4 (3.9–4.9)
 PLT (109/L) 113 (78–153)
 ALT (U/L) 49.0 (25.0–152.5)
 AST (U/L) 75.0 (39.0–158.5)
 GGT (U/L) 100.7 (61.8–164.8)
 ALP (U/L) 122.0 (86.8–191.3)
 TB (μmol/L) 33.3 (19.7–47.0)
 DB (μmol/L) 21.5 (12.7–30.5)
 ALB (g/L) 30.6 (27.7–33.6)
 PT (s) 14.8 (12.7–17.0)
 BUN (mmol/L) 5.5 (3.8–7.9)
 CR (μmol/L) 74.0 (60.0–90.0)
 CA-125 (U/ml) 259.9 (182.1–458.4)
 CA199 13.04 (7.9–34.2)
Treatment, n (%)
 Non-anticoagulation 26 (22.2)
 Anticoagulation 74 (63.2)
 Anticoagulation + TIPS 17 (14.5)
  1. WBC white blood cell count, RBC red blood cell count, PLT platelet count, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT λ-glutamyl transferase, ALP alkaline phosphatase, TB total bilirubin, DB direct bilirubin, TP total protein, ALB albumin, BUN blood urea nitrogen, CR creatinine, PT prothrombin time, TIPS transjugular intrahepatic portosystemic shunt